captureselect human fab-lambda kinetics biotin conjugate (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
captureselect human fab-lambda kinetics biotin conjugate
Captureselect Human Fab Lambda Kinetics Biotin Conjugate, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+fab+lambda/captureselecttm+human+fab+kappa+kinetics+biotin+conjugate+ligand/us12304960-1121-20-27
Average 90 stars, based on 1 article reviews
Captureselect Human Fab Lambda Kinetics Biotin Conjugate, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+fab+lambda/captureselecttm+human+fab+kappa+kinetics+biotin+conjugate+ligand/us12304960-1121-20-27
Average 90 stars, based on 1 article reviews
captureselect human fab-lambda kinetics biotin conjugate - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Binding Assay:Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: About 1000 RU of antibody was captured using a sensor chip immobilized with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: A plasmid (Origene Technologies Cat #RC220706) encoding the human NRP2 variant 2 transcript NM_003872 (hNRP2) fused to a Myc-DDK tag was purchased. Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 400 RU of an antibody comprising an Fc region is first captured onto a sensor chip, onto which Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: For the antibody (Fc) variants and Fc only variants, we aimed for initial immobilization to achieve response unit (RU) signals of approximately 60 for antibody variants and between 60 and 80 for Fc only variants, using the Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 1000 RU of an antibody comprising a variant Fc region is first captured onto a sensor chip, with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: Running buffer: 50 mM HEPES, 300 mM NaCl, 5 mM CaCl2, 0.005% Tween-20, pH 7.4 Immobilized antibody: Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: First, Article Title: Efficient production of bispecific antibody by FAST-Ig TM and its application to NXT007 for the treatment of hemophilia A. Article Snippet: The Variant Assay:Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: About 1000 RU of antibody was captured using a sensor chip immobilized with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: A plasmid (Origene Technologies Cat #RC220706) encoding the human NRP2 variant 2 transcript NM_003872 (hNRP2) fused to a Myc-DDK tag was purchased. Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 400 RU of an antibody comprising an Fc region is first captured onto a sensor chip, onto which Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: For the antibody (Fc) variants and Fc only variants, we aimed for initial immobilization to achieve response unit (RU) signals of approximately 60 for antibody variants and between 60 and 80 for Fc only variants, using the Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 1000 RU of an antibody comprising a variant Fc region is first captured onto a sensor chip, with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: Running buffer: 50 mM HEPES, 300 mM NaCl, 5 mM CaCl2, 0.005% Tween-20, pH 7.4 Immobilized antibody: Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: First, Article Title: Efficient production of bispecific antibody by FAST-Ig TM and its application to NXT007 for the treatment of hemophilia A. Article Snippet: The Construct:Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: About 1000 RU of antibody was captured using a sensor chip immobilized with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: A plasmid (Origene Technologies Cat #RC220706) encoding the human NRP2 variant 2 transcript NM_003872 (hNRP2) fused to a Myc-DDK tag was purchased. Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 400 RU of an antibody comprising an Fc region is first captured onto a sensor chip, onto which Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: For the antibody (Fc) variants and Fc only variants, we aimed for initial immobilization to achieve response unit (RU) signals of approximately 60 for antibody variants and between 60 and 80 for Fc only variants, using the Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 1000 RU of an antibody comprising a variant Fc region is first captured onto a sensor chip, with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: Running buffer: 50 mM HEPES, 300 mM NaCl, 5 mM CaCl2, 0.005% Tween-20, pH 7.4 Immobilized antibody: Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: First, Article Title: Efficient production of bispecific antibody by FAST-Ig TM and its application to NXT007 for the treatment of hemophilia A. Article Snippet: The Comparison:Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: About 1000 RU of antibody was captured using a sensor chip immobilized with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: A plasmid (Origene Technologies Cat #RC220706) encoding the human NRP2 variant 2 transcript NM_003872 (hNRP2) fused to a Myc-DDK tag was purchased. Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 400 RU of an antibody comprising an Fc region is first captured onto a sensor chip, onto which Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: For the antibody (Fc) variants and Fc only variants, we aimed for initial immobilization to achieve response unit (RU) signals of approximately 60 for antibody variants and between 60 and 80 for Fc only variants, using the Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 1000 RU of an antibody comprising a variant Fc region is first captured onto a sensor chip, with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: Running buffer: 50 mM HEPES, 300 mM NaCl, 5 mM CaCl2, 0.005% Tween-20, pH 7.4 Immobilized antibody: Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: First, Article Title: Efficient production of bispecific antibody by FAST-Ig TM and its application to NXT007 for the treatment of hemophilia A. Article Snippet: The Control:Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: About 1000 RU of antibody was captured using a sensor chip immobilized with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: A plasmid (Origene Technologies Cat #RC220706) encoding the human NRP2 variant 2 transcript NM_003872 (hNRP2) fused to a Myc-DDK tag was purchased. Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 400 RU of an antibody comprising an Fc region is first captured onto a sensor chip, onto which Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: For the antibody (Fc) variants and Fc only variants, we aimed for initial immobilization to achieve response unit (RU) signals of approximately 60 for antibody variants and between 60 and 80 for Fc only variants, using the Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 1000 RU of an antibody comprising a variant Fc region is first captured onto a sensor chip, with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: Running buffer: 50 mM HEPES, 300 mM NaCl, 5 mM CaCl2, 0.005% Tween-20, pH 7.4 Immobilized antibody: Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: First, Article Title: Efficient production of bispecific antibody by FAST-Ig TM and its application to NXT007 for the treatment of hemophilia A. Article Snippet: The Purification:Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: About 1000 RU of antibody was captured using a sensor chip immobilized with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: A plasmid (Origene Technologies Cat #RC220706) encoding the human NRP2 variant 2 transcript NM_003872 (hNRP2) fused to a Myc-DDK tag was purchased. Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 400 RU of an antibody comprising an Fc region is first captured onto a sensor chip, onto which Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: For the antibody (Fc) variants and Fc only variants, we aimed for initial immobilization to achieve response unit (RU) signals of approximately 60 for antibody variants and between 60 and 80 for Fc only variants, using the Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 1000 RU of an antibody comprising a variant Fc region is first captured onto a sensor chip, with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: Running buffer: 50 mM HEPES, 300 mM NaCl, 5 mM CaCl2, 0.005% Tween-20, pH 7.4 Immobilized antibody: Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: First, Article Title: Efficient production of bispecific antibody by FAST-Ig TM and its application to NXT007 for the treatment of hemophilia A. Article Snippet: The Plasmid Preparation:Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: About 1000 RU of antibody was captured using a sensor chip immobilized with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: A plasmid (Origene Technologies Cat #RC220706) encoding the human NRP2 variant 2 transcript NM_003872 (hNRP2) fused to a Myc-DDK tag was purchased. Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 400 RU of an antibody comprising an Fc region is first captured onto a sensor chip, onto which Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: For the antibody (Fc) variants and Fc only variants, we aimed for initial immobilization to achieve response unit (RU) signals of approximately 60 for antibody variants and between 60 and 80 for Fc only variants, using the Article Title: Anti-CD137 antigen-binding molecule and utilization thereof Article Snippet: Specifically, about 1000 RU of an antibody comprising a variant Fc region is first captured onto a sensor chip, with Article Title: Therapeutic compositions comprising anti-NRP2 antibodies Article Snippet: Running buffer: 50 mM HEPES, 300 mM NaCl, 5 mM CaCl2, 0.005% Tween-20, pH 7.4 Immobilized antibody: Article Title: TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization Article Snippet: First, Article Title: Efficient production of bispecific antibody by FAST-Ig TM and its application to NXT007 for the treatment of hemophilia A. Article Snippet: The |